Money makers: 10 midcap stocks for gains in this volatile market Read more at: http://www.moneycontrol.com/news/stocks-views/money-makers-10-midcap-stocks-for-gainsthis-volatile-market_997298-8139.html?utm_source=ref_article

 Biocon Rating: ACCUMULATE Target: Rs 399 Upside: 9% Rationale: Biopharma and contract research segment is expected to grow by 15% and 21% over FY13-15E. Strategic partnerships with BMS/Mylan ensures higher visibiltiy in earnings going forward. Anticipate 24% earnings growth over FY13-15E.

Read more at: http://www.moneycontrol.com/news/stocks-views/money-makers-10-midcap-stocks-for-gainsthis-volatile-market_997298-8139.html?utm_source=ref_article